No black box warning on record for Opdivo Qvantig
As of the latest FDA labeling reviewed, Opdivo Qvantig (NIVOLUMAB AND HYALURONIDASE-NVHY) does not carry a black box warning. Standard warnings and precautions still apply — see the full Opdivo Qvantig medicine page for the complete safety profile.